Advertisement

BMC Surgery

, 18:20 | Cite as

Successful pulmonary arterial embolization followed by curative surgery for a lepidic predominant lung adenocarcinoma with severe hypoxemia

  • Louise Sebane
  • Mostafa El-Hajjam
  • Philippe Puyo
  • Elisabeth Longchampt
  • Etienne Giroux Leprieur
Open Access
Case report
Part of the following topical collections:
  1. Vascular and thoracic surgery

Abstract

Background

Lepidic predominant adenocarcinoma is characterized by frequent refractory hypoxemia due to intrapulmonary shunting. Severe hypoxemia can induce perioperative complications in case of thoracic surgery.

Case presentation

We report a case of a 67 year-old woman with localized lepidic adenocarcinoma in the right lower lobe with severe hypoxemia. A selective arterial lung embolization allowed an instantaneous correction of the hypoxemia, and a curative lobectomy was safely performed 1 week after without any complication. The staging was pT3N0M0, and the patient received adjuvant chemotherapy.

Conclusions

This is the first case-report of successful endovascular embolization before curative surgery for a lepidic predominant lung adenocarcinoma.

Keywords

Thoracic surgery Non-small cell lung cancer Lepidic adenocarcinoma Hypoxemia Arterial embolization 

Abbreviations

CK7

Cytokeratin 7

CT-scan

Computerized-tomography scan

DLCO

Diffusing capacity of the lung for carbon monoxide

FEV1

Forced expiratory volume in one second

IHC

Immunohistochemistry

NSCLC

Non-small cell lung cancer

TTF1

Thyroid Transcription Factor-1

Background

Adenocarcinoma is the most frequent histological subtype in non-small cell lung cancer (NSCLC). Lepidic predominant subtype is a particular form of invasive lung adenocarcinoma, developed initially from Club cells and/or type II pneumocytes [1]. The alveolar spreading induces a specific clinical and radiological presentation, with dyspnea, cough, ground-glass attenuations and alveolar consolidations on CT-scan [1]. The presence of severe hypoxemia represents an issue in case of localized tumour with indication of surgical resection. We present here the case of a 67 year-old women with localized lepidic predominant adenocarcinoma and severe hypoxemia due to intrapulmonary shunting, who was successfully treated by pulmonary arterio-embolization followed by curative lower lobe resection.

Case presentation

A 67 year-old woman was admitted to the Department of Respiratory Diseases and Thoracic Oncology for dyspnea, increasing over a few weeks, without infectious context. Her medical history was a breast cancer in 2006 treated by surgery, chemotherapy and radiotherapy, without evidence of recurrence, diabetes, systemic hypertension and an active smoking at 40 packet-years. The oxygen saturation at the admission was at 80% in room air, with need for supplementation of oxygen at 6 l/min. Arterial blood gas on 6 l/min O2 supplementation showed a PO2 of 70 mmHg, a PCO2 of 39 mmHg and pH of 7.42. Functional tests showed a moderate obstructive syndrome, with a forced expiratory volume in 1 sec (FEV1) on vital capacity ratio at 66%, and a FEV1 at 1350 ml (62%). Unfortunately, the evaluation of diffusing capacity of the lung for carbon monoxide (DLCO) was not feasible at the time of the diagnosis, due to the severity of dyspnea. The CT-scan revealed ground-glass opacities and alveolar consolidation in the right lower lobe (Fig. 1). Transthoracic echocardiography demonstrated normal left ventricular ejection fraction. Cytology on bronchial aspiration and right lower lobe transbronchial biopsy found adenocarcinomatous cells with positive staining for Thyroid Transcription Factor-1 (TTF-1) in immunohistochemistry (IHC). Brain CT-scan was normal, and PET-CT showed localized hypermetabolism on the right lower lobe. A pulmonary angiography was performed. The temporary balloon occlusion of the right lower pulmonary artery showed a rapid increase of the oxygen rate from 90% on oxygen 6 L/mn to 100% in room air, and the patient underwent thereafter an intravascular occlusion of this artery by coils and plugs (Fig. 2). The oxygen saturation increased instantly to 100% at room air; arterial blood gas at room air showed a PO2 of 82 mmHg, a PCO2 of 33 mmHg and a pH of 7.43. One week later, a lower right lobectomy with mediastinal lymphadenectomy was performed without post-operative complication. The pathological study showed a 9 cm-sized lepidic predominant adenocarcinoma (pT3N0M0), with necrotic and hemorrhagic changes due to the embolization, and Cytokeratin 7 (CK7) and TTF-1 positive IHC staining. The patient received adjuvant cisplatin and vinorelbine chemotherapy.
Fig. 1

CT-scan showing ground-glass opacities and alveolar consolidation in the right lower lobe

Fig. 2

Successful intravascular occlusion of the right lower lung artery by coils and plugs

Discussion and conclusion

The deep hypoxemia observed occasionally in lepidic lung adenocarcinoma is due to the filling of alveolar spaces by tumor cells, along with normal perfusion of these territories. This phenomenon induces a veno-arterial shunting, with hypoxemia and normocapnia. The first description was made in 1969 by Wolinsky and Williams, with a case of diffuse bronchio-alveolar lung adenocarcinoma showing hypoxemia, normal lung angiogram and normal pulmonary function tests [2]. Since then, only a few cases of lepidic adenocarcinoma treated by surgery have been reported [3, 4, 5, 6, 7, 8, 9, 10]. The surgery induced an improvement of hypoxemia and symptoms in all patients, with an overall survival after surgery between 21 days and 24 months in such a palliative context. However, the management of the hypoxemia due to intrapulmonary shunting with perfusion of a non-ventilated lobe, is not codified. The possibility of surgical ligation of the vessels in the lower lobe during the thoracotomy was considered for our patient, but we chose to correct the deep hypoxemia before the surgery, as deep hypoxemia can be a source of complications during the perioperative time, and is reported to be a prognostic factor [11, 12, 13].

The temporary balloon occlusion is a good indicator of the potential benefit of surgery or embolization. Wartzki et al. described a case of left pneumonectomy for a stage III adenocarcinoma performed after a temporary balloon occlusion showing a correction of the shunting [8]. One case of palliative embolization was reported, in 2015 [9]. In this case of an extensive bilateral lung disease, the procedure failed to demonstrate a PO2 improvement but it induced a clear improvement of the dyspnea. Finally, the association of the two procedures (embolization then surgery) has only been reported in one case [10]. It was also a palliative situation and the association of these two procedures allowed an improvement of the dyspnea and the PO2.

Our case is the first to describe the successful pre-surgical management of a lepidic predominant adenocarcinoma with a curative objective. The occlusion of the right lower lung artery allowed in our patient a rapid and prolonged improvement of the haematosis with a complete correction of the hypoxemia. The surgery was then performed safely with optimal respiratory conditions and without any complication.

In conclusion, the occlusion of the right to left shunt by endovascular embolization is a safe and efficient procedure before curative surgery for lepidic predominant lung adenocarcinoma.

Notes

Acknowledgements

There is nothing to be acknowledged.

Funding

For this study no funding exists.

Availability of data and materials

The data supporting our thesis is completely available in this article. Articles referred to can be found in the reference list.

Authors’ contributions

LS and EGL collected the data; EGL supervised the work; MEH made the arterial embolization; PP made the surgery; EL made the pathological analyses; all authors reviewed the manuscript. All authors read and approved the final version of the manuscript.

Authors’ information

Not applicable.

Ethics approval and consent to participate

Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review.

This case report study was carried out respecting the Declaration of Helsinki in its current version. Ethical approval: not applicable.

Consent for publication

Written informed consent was obtained from the patient for publication of this Case report and any accompanying images.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244–85.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Wolinsky H, Lin A, Williams MH Jr. Lung perfusion in bronchiolo-alveolar carcinoma. A case report. Am Rev Respir Dis. 1969;99:585–9.PubMedGoogle Scholar
  3. 3.
    Barlesi F, Doddoli C, Thomas P, Kleisbauer JP, Giudicelli R, Fuentes P. Bilateral bronchioloalveolar lung carcinoma: is there a place for palliative pneumonectomy? Eur J Cardiothorac Surg. 2001;20(6):1113–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Chetty KG, Dick C, McGovern J, Conroy RM, Mahutte CK. Refractory hypoxemia due to intrapulmonary shunting associated with bronchioloalveolar carcinoma. Chest. 1997;111(4):1120–1.CrossRefPubMedGoogle Scholar
  5. 5.
    Falcoz PE, Hoan NT, Le Pimpec-Barthes F, Riquet M. Severe hypoxemia due to intrapulmonary shunting requiring surgery for bronchioloalveolar carcinoma. Ann Thorac Surg. 2009;88(1):287–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Fishman HC, Danon J, Koopot N, Langston HT, Sharp JT. Massive intra- pulmonary venoarterial shunting in alveolar cell carcinoma. A case report. Am Rev Respir Dis. 1974;109(1):124–8.PubMedGoogle Scholar
  7. 7.
    Sarlin RF, Schillaci RF, Georges TN, Wilcox JR. Focal increased lung perfusion and intrapulmonary veno-arterial shunting in bronchiolo-alveolar cell carcinoma. Am J Med. 1980;68(4):618–23.CrossRefPubMedGoogle Scholar
  8. 8.
    Wartski M, Zerbib E, Regnard JF, Herve P. Reverse ventilation-perfusion mismatch in lung Cancer suggests intrapulmonary functional shunting. J Nucl Med. 1998;39:1986–9.PubMedGoogle Scholar
  9. 9.
    Tan JYA, Walters DL, Poon K, Zimmerman P, Aldons P. Palliative embolisation for intrapulmonary shunting in lepidic predominant adenocarcinoma of the lung. Respir Med Case Rep. 2015;15:121–4.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Crossno PF, Milstone AP, Lambright ES, Carbone DP, Light RW. Severe intrapulmonary shunting in bronchioloalveolar cell carcinoma corrected by selective pulmonary artery occlusion and palliative tumor resection. Chest. 2006;130(4Meetingabstracts):313S-c-314S.Google Scholar
  11. 11.
    Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e166S–90S.CrossRefPubMedGoogle Scholar
  12. 12.
    Celli BR. What is the value of preoperative pulmonary function testing? Med Clin North Am. 1993;77(2):309–25.CrossRefPubMedGoogle Scholar
  13. 13.
    Zibrak JD, O’Donnell CR, Marton K. Indications for pulmonary function testing. Ann Intern Med. 1990;112(10):763–71.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Department of Respiratory Diseases and Thoracic OncologyAPHP - Ambroise Pare HospitalBoulogne-BillancourtFrance
  2. 2.Department of RadiologyAPHP - Ambroise Pare HospitalBoulogne-BillancourtFrance
  3. 3.Department of Thoracic SurgeryFoch HospitalSuresnesFrance
  4. 4.Department of PathologyFoch HospitalSuresnesFrance
  5. 5.EA4340, UVSQ, Paris-Saclay UniversityBoulogne-BillancourtFrance

Personalised recommendations